[{"Assets_0_Q2_USD":1759403000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":17657000.0,"NetIncomeLoss_1_Q2_USD":5695000.0,"NetIncomeLoss_2_Q2_USD":6716000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":28228000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":28276000.0,"StockholdersEquity_0_Q2_USD":697009000.0,"EarningsPerShareBasic_1_Q2_USD":0.2,"EarningsPerShareBasic_2_Q2_USD":0.24,"Ticker":"CNMD","CIK":"816956","name":"CONMED CORP","OfficialName":"CONMED Corporation Common Stock","form":"10-Q","period":"20190630","fy":"2019.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"4404922313.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Electromedical & Electrotherapeutic Apparatus","Market":"NYSE","SP500":"nan","filed":"20190801"}]